Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1431 of 6351
-
Can CAR-T Therapy's Long-Term safety be tracked in the real world?
Knowledge-focused OngoingThis non-interventional study will use information already reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) registry during routine clinical care. The study will assess the long-term safety and effectiveness of lisocabtagene maraleucel in par…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New brain tumor scan could sharpen treatment decisions
Diagnosis Recruiting nowThis phase II trial studies how well the addition of 18F-DOPA (amino acid) positron emission tomography (PET)/computed tomography (CT) to standard of care (SOC) imaging can improve the clinical management of patients with brain tumors in over 50% of cases. PET is an imaging test …
Phase 2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
Could less be more? new trial tests lower drug dose to tame myeloma side effects
Disease control Recruiting nowThis phase I/II trial evaluates the safety and feasibility of early, response-based dose reduction of linvoseltamab in the treatment of patients multiple myeloma that has come back after a period of improvement (relapsed), that does not respond to treatment (refractory), or that …
Phase 1/2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New mRNA vaccine takes on tough cancers
Disease control Recruiting nowThis is a multicenter, open-label Phase 1 clinical study to evaluate the safety, tolerability, immunogenicity, pharmacokinetic (PK) and pharmacodynamic (PD) characteristics, as well as preliminary anti-tumor activity of ABO2102 as monotherapy and in combination among participants…
Phase 1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a fruit compound clear old cells and fight aging?
Disease control Recruiting nowThe accumulation of senescent cells with age is a central mechanism that contributes to the development of chronic diseases, primarily by driving systemic chronic inflammation. Senolytic compounds such as fisetin can selectively target senescent cells for elimination and reduce m…
Phase 1/2 • Sponsor: Ove Andersen • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could adding common diabetes pills improve type 1 control?
Disease control Recruiting nowThis will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual car…
Sponsor: Indiana University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New eye drop could ease severe allergy in kids
Disease control Recruiting nowThe aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stroke study to settle anesthesia debate: sleep or sedate?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn what is the best anesthetic management in participants with severe stroke that require a medical intervention called mechanical thrombectomy (MT) done to open the occluded brain vessel. The main question it aims to answer is: • Is gen…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
AI and blood tests aim to catch pancreatic cancer earlier
Knowledge-focused Recruiting nowThis clinical trial studies a new screening program to improve the early detection of sporadic pancreatic cancer in individuals with a high risk of developing pancreatic cancer. Pancreatic cancer remains one of the deadliest solid tumors, characterized by a long phase without sym…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Warm baths may boost heart health for spinal injury patients
Disease control Recruiting nowThe study is designed to investigate the effects of passive heat therapy on blood vessel health in 40 people (48 enrolled with attrition rate of 20%). Following an extensive set of vascular function tests, participants will engage in either a passive heat therapy intervention for…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Cancer drug could ease rare nerve disorder
Disease control Recruiting nowThe MAZINGA study is a multicenter, open-label, single-arm Phase IIA clinical trial designed to evaluate the efficacy, safety, and tolerability of zanubrutinib in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) antibody-associated demyelinating polyneuropathy. An…
Phase 2 • Sponsor: Azienda Ospedaliera di Padova • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug cocktail aims to tame kidney cancer
Disease control Recruiting nowTo find out if the combination of HC-7366 and nivolumab (with or without ipilimumab) can help to control ccRCC. The
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Light therapy may boost IVF success for older women
Disease control Recruiting nowOocytes need a lot of energy to complete meiosis and fertilize successfully. As women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for eggs and embryos to develop normally. One possible way to help is with a gentle ligh…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI reads your social media to boost breast cancer mental health
Symptom relief OngoingThis study (study type: randomized controlled trial) aims to evaluate whether a large language model-based precision emotional management intervention can improve health-related quality of life among patients with primary breast cancer. The study will enroll adult women (≥18 year…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Ultrasound during artery stenting may cut stroke risk
Disease control Recruiting nowCarotid artery stenting (CAS) prevents stroke but carries risks of perioperative cerebral embolism. Transcranial Doppler (TCD) ultrasound can detect microemboli during CAS and may offer therapeutic benefits through ultrasound-enhanced thrombolysis. Trials like SONOBUSTER and SONO…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New shot aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThe purpose of this protocol is to evaluate the efficacy of MK-8690 in participants with moderately to severely active ulcerative colitis. The primary hypothesis is that MK-8690 is superior to placebo with respect to the proportion of participants achieving clinical remission per…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
New hope for immunocompromised skin cancer patients: amivantamab combo tested
Disease control PausedThis phase II trial compares the effect of amivantamab and hyaluronidase to cetuximab for the treatment of skin (cutaneous) squamous cell carcinoma that has come back after a period of improvement and has not spread to other parts of the body (locally recurrent) or that has sprea…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New CAR-T therapy aims to tackle tough lymphoma
Disease control Not yet recruitingThis single-arm, open-label pilot study will assess the safety and efficacy of RN1701, a bispecific CD19/CD20-targeted allogeneic CAR-T-cell product, in patients with relapsed or refractory B-cell lymphoma. Up to 19 participants will be enrolled in a conventional 3 + 3 dose-escal…
Phase 1/2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo shows promise for tough bile duct cancer in early trial
Disease control Recruiting nowBiliary tract carcinoma (BTC) is a highly aggressive malignancy with rising incidence worldwide. Most patients present at an advanced stage and have a dismal prognosis. First-line gemcitabine-platinum plus PD-1/PD-L1 blockade has become the new standard, yet no established second…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Good bacteria vs. bad: new trial aims to stop BV from coming back
Disease control Recruiting nowRecurrent bacterial vaginosis is a common condition in women of reproductive age and is characterized by a disruption of the normal vaginal microbiota, with a reduction in Lactobacillus species and an overgrowth of anaerobic bacteria such as Gardnerella vaginalis. Recurrence rate…
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC